Sandbox/table
< Sandbox
The following table contains the main risk factors for CDI:[1][2][3][2][2]
Alterations in the coagulation system |
---|
Consumption of clotting factors |
Increased concentrations of fibrin degradation products |
Disseminated intravascular coagulation |
table
Ebola virus strain | Place of discovery | Date |
---|---|---|
Sudan ebolavirus | Sudan | Between June and November 1976 |
Zaire ebolavirus | Yambuku, Democratic Republic of the Congo (formerly Zaire) | Between August and November 1976 |
Reston ebolavirus | Reston, Virginia, US. | November 1989 |
Ivory Coast ebolavirus | Tai Forest, Cote d'Ivoire. | November 1994 |
Bundibugyo ebolavirus | Bundibugyo District, Uganda | November 2007 |
table
Diagnostic test | North America | South America | Middle East | Far East |
---|---|---|---|---|
ELISA (serology) detects:
|
† There is a reported prevalence of 15% in the Northeast of the US.
- ↑ Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ (2012). "Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics". J Antimicrob Chemother. 67 (3): 742–8. doi:10.1093/jac/dkr508. PMID 22146873.
- ↑ 2.0 2.1 2.2 Knight, Christopher L.; Surawicz, Christina M. (2013). "Clostridium difficile Infection". Medical Clinics of North America. 97 (4): 523–536. doi:10.1016/j.mcna.2013.02.003. ISSN 0025-7125.
- ↑ Planche, Tim (2013). "Clostridium difficile". Medicine. 41 (11): 654–657. doi:10.1016/j.mpmed.2013.08.003. ISSN 1357-3039.